{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:34:19Z","timestamp":1782189259489,"version":"3.54.5"},"reference-count":31,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"unspecified","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009128","name":"Research for Patient Benefit Programme","doi-asserted-by":"publisher","award":["PB-PG-0418-20006"],"award-info":[{"award-number":["PB-PG-0418-20006"]}],"id":[{"id":"10.13039\/501100009128","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,1,21]]},"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>We conducted a feasibility study to evaluate the feasibility of recruiting patients to examine the effect of near vision glasses in young infants at risk of cerebral visual impairment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A three-arm, parallel-group, open-label randomised feasibility trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Tertiary neonatal intensive care in London, UK.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>We included babies born before 29 weeks of gestation or at full term with hypoxic ischaemic encephalopathy. Babies who needed ongoing inpatient care, with established eye anomalies or with very high refractive errors at baseline (&lt;\u22126.00 dioptres (D) or &gt;\u00b18.00D) were not included. Infants with retinopathy of prematurity were not excluded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>At 8 weeks corrected age, we allocated 18 infants to wear glasses (+3.00D over full cycloplegic refraction) immediately (intervention 1), 18 to wear the same glasses at 16 weeks (intervention 2) and 19 infants were allocated to standard treatment (no glasses).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes<\/jats:title>\n                    <jats:p>Recruitment and retention of study participants (primary), compliance wearing glasses, preferential-looking visual acuity (with glasses) and visual function as determined using A Test Battery of Child Development for Examining Functional Vision at 3-month and 6-month age post-term.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 70 eligible families, 55 consented and 34 attended baseline assessments, and 28 completed the study. Non-attendance was due mainly to prolonged inpatient stay, infant health and scheduling conflicts. Glasses were worn for similar periods in each group (Intervention 1: median 2\u2009hours\/day (95%\u2009CI 1\u2009hour to 4\u2009hours); Intervention 2: median 2\u2009hours\/day (95%\u2009CI 1.5\u2009hours to 3\u2009hours)). Visual acuity improved from baseline to 6 months. Mean (SE) LogMAR (Minimum Angle of Resolution) improvements were standard care: 0.47 (0.45); intervention 1: 0.66 (0.44); intervention 2: 0.37 (0.36). Among the 29 very preterm infants, there were similar findings: standard care: 0.35 (0.35); Intervention 1: 0.67 (0.47); Intervention 2: 0.34 (0.40). As a functional measure, object permanence was present at the following rates by randomised arm: standard care: 29%; whereas intervention 1: 56%; and intervention 2: 44% (OR intervention 1\u2009vs standard care: 3.13 (95% CI 0.38 to 25.57), ie, not statistically significant).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We demonstrate feasibility for a definitive RCT (randomized controlled trial) with good recruitment and retention and observed potential benefits for vision and development following the dispensing of glasses at 8 weeks post-term age compared with untreated controls. We identified methodological modifications to further improve recruitment processes for a future larger study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration numbers<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"isrctn\" xlink:href=\"ISRCTN14646770\">ISRCTN14646770<\/jats:ext-link>\n                      ;\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05048550\">NCT05048550<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-107894","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T14:55:31Z","timestamp":1771253731000},"page":"e107894","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Can provision of near vision glasses as an early intervention improve visual outcomes in infants at risk of perinatal brain insult? The Babies in Glasses (BiG) randomised feasibility trial"],"prefix":"10.1136","volume":"16","clinical-trial-number":[{"clinical-trial-number":"isrctn14646770","registry":"10.18810\/isrctn"},{"clinical-trial-number":"nct05048550","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2687-1926","authenticated-orcid":false,"given":"Raimonda","family":"Bullaj","sequence":"first","affiliation":[{"name":"Ophthalmology, Great Ormond Street Hospital NHS Trust, London, UK"},{"name":"Institute for Women\u2019s Health, University College London Hospitals NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh","family":"Dyet","sequence":"additional","affiliation":[{"name":"Institute for Women\u2019s Health, University College London Hospitals NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhabrata","family":"Mitra","sequence":"additional","affiliation":[{"name":"University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0935-3713","authenticated-orcid":false,"given":"Catey","family":"Bunce","sequence":"additional","affiliation":[{"name":"London School of Hygiene & Tropical Medicine Faculty of Infectious and Tropical Diseases, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4676-1257","authenticated-orcid":false,"given":"Caroline S","family":"Clarke","sequence":"additional","affiliation":[{"name":"Research Department of Primary Care and Population Health, University College London, UCL Medical School, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9289-5731","authenticated-orcid":false,"given":"Kathryn","family":"Saunders","sequence":"additional","affiliation":[{"name":"Biomedical Sciences Research Institute, Ulster University, Coleraine, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Dale","sequence":"additional","affiliation":[{"name":"Great Ormond Street Hospital for Children, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Horwood","sequence":"additional","affiliation":[{"name":"School of Psychology, University of Reading, Reading, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9133-2021","authenticated-orcid":false,"given":"Cathy","family":"Williams","sequence":"additional","affiliation":[{"name":"Bristol Medical School, University of Bristol, Bristol, UK"},{"name":"University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"St Clair Tracy","sequence":"additional","affiliation":[{"name":"School of Medicine, University of St Andrews, St Andrews, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Marlow","sequence":"additional","affiliation":[{"name":"University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5422-4104","authenticated-orcid":false,"given":"Richard","family":"Bowman","sequence":"additional","affiliation":[{"name":"International Centre for Eye Health, London School of Hygiene & Tropical Medicine, London, UK"},{"name":"Institute of Child Health, UCL, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"2026021609461135000_16.2.e107894.1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2017-310694"},{"key":"2026021609461135000_16.2.e107894.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14631-4"},{"key":"2026021609461135000_16.2.e107894.3","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S2352-4642(20)30366-7","article-title":"Visual impairment, severe visual impairment, and blindness in children in Britain (BCVIS2): a national observational study","volume":"5","author":"Teoh","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"key":"2026021609461135000_16.2.e107894.4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014772","article-title":"Visual perceptual difficulties and under-achievement at school: neuronal injury is now the commonest cause of blindness or severe visual impairment amongst children in the UK","volume":"6","author":"Williams","year":"2011","journal-title":"PLoS ONE"},{"key":"2026021609461135000_16.2.e107894.5","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2017-313707"},{"key":"2026021609461135000_16.2.e107894.6","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_1274_17"},{"key":"2026021609461135000_16.2.e107894.7","doi-asserted-by":"publisher","DOI":"10.1007\/s10633-013-9405-y"},{"key":"2026021609461135000_16.2.e107894.8","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2020-318998"},{"key":"2026021609461135000_16.2.e107894.9","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.05-0825"},{"key":"2026021609461135000_16.2.e107894.10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pediatrneurol.2023.11.002","article-title":"Neurological and Visual Outcomes in Infants and Toddlers Following Therapeutic Hypothermia for Neonatal Hypoxic-Ischemic Encephalopathy","volume":"151","author":"Imamoglu","year":"2024","journal-title":"Pediatr Neurol"},{"key":"2026021609461135000_16.2.e107894.11","doi-asserted-by":"publisher","DOI":"10.1016\/0275-5408(95)00138-7"},{"key":"2026021609461135000_16.2.e107894.12","doi-asserted-by":"publisher","DOI":"10.1152\/jn.1965.28.6.1060"},{"key":"2026021609461135000_16.2.e107894.13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ophtha.2017.09.032","article-title":"Pediatric Eye Evaluations Preferred Practice Pattern\u00ae: I. Vision Screening in the Primary Care and Community Setting; II. Comprehensive Ophthalmic Examination","volume":"125","author":"Wallace","year":"2018","journal-title":"Ophthalmology"},{"key":"2026021609461135000_16.2.e107894.14","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S2352-4642(18)30317-1","article-title":"5-year outcomes after primary intraocular lens implantation in children aged 2 years or younger with congenital or infantile cataract: findings from the IoLunder2 prospective inception cohort study","volume":"2","author":"Solebo","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"2026021609461135000_16.2.e107894.15","doi-asserted-by":"publisher","DOI":"10.1097\/OPX.0b013e318031b69a"},{"key":"2026021609461135000_16.2.e107894.16","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jaapos.2017.07.206","article-title":"Response to correction of refractive errors and hypoaccommodation in children with congenital Zika syndrome","volume":"21","author":"Ventura","year":"2017","journal-title":"J AAPOS"},{"key":"2026021609461135000_16.2.e107894.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2017.07.011"},{"key":"2026021609461135000_16.2.e107894.18","unstructured":"Saunders KJ , McClelland JF . Spectacle intervention in children with cerebral palsy (CP) and accommodative dysfunction. Invest Ophthalmol Vis Sci 2004;45."},{"key":"2026021609461135000_16.2.e107894.19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10633-023-09948-5","article-title":"Pattern visual evoked potential and foveal sensitivity in amblyopia","volume":"147","author":"Dahal","year":"2023","journal-title":"Doc Ophthalmol"},{"key":"2026021609461135000_16.2.e107894.20","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3928\/0191-3913-19870701-06","article-title":"Adie\u2019s syndrome as a cause of amblyopia","volume":"24","author":"Agbeja","year":"1987","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"2026021609461135000_16.2.e107894.21","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0002-9394(99)00039-2","article-title":"Adie syndrome: evidence for refractive error and accomodative asymmetry as the cause of amblyopia","volume":"128","author":"Firth","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"2026021609461135000_16.2.e107894.22","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-059946","article-title":"Effectiveness of early spectacle intervention on visual outcomes in babies at risk of cerebral visual impairment: a parallel group, open-label, randomised clinical feasibility trial protocol","volume":"12","author":"Bullaj","year":"2022","journal-title":"BMJ Open"},{"key":"2026021609461135000_16.2.e107894.23","doi-asserted-by":"publisher","DOI":"10.1076\/stra.10.4.245.13831"},{"key":"2026021609461135000_16.2.e107894.24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1475-1313.2009.00679.x"},{"key":"2026021609461135000_16.2.e107894.25","unstructured":"Jones KC , Weatherly H , Birch S , et al . Unit costs of health and social care 2024 manual, Report No.: 10.22024\/UniKent\/01.02.109563. Canterbury PSSRU, University of Kent & Centre for Health Economics, University of York; 2025."},{"key":"2026021609461135000_16.2.e107894.26","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.86.9.1035"},{"key":"2026021609461135000_16.2.e107894.27","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-973693"},{"key":"2026021609461135000_16.2.e107894.28","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/sj.eye.6702838","article-title":"Ophthalmological problems associated with preterm birth","volume":"21","author":"O\u2019Connor","year":"2007","journal-title":"Eye (Lond)"},{"key":"2026021609461135000_16.2.e107894.29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/apa.17417","article-title":"Gestational age, maternal smoking, neurological lesion and retinopathy predict strabismus at age 5.5 in preterm children","volume":"114","author":"Chapron","year":"2025","journal-title":"Acta Paediatr"},{"key":"2026021609461135000_16.2.e107894.30","unstructured":"Gale C , Modi N , Hall J , et al . DOLFIN: developmental outcomes of long-term feed supplementation in neonates. A randomised placebo-controlled trial (NIHR130925). London National Institute for Health and Care Research; 2022. Available: https:\/\/www.isrctn.com\/ISRCTN62323236"},{"key":"2026021609461135000_16.2.e107894.31","unstructured":"National Institute for Health and Care Excellence (NICE) . Developmental follow-up of children and young people born preterm [NG72]. London NICE; 2017."}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-107894","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T17:47:10Z","timestamp":1771264030000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-107894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,16]]},"published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1136\/bmjopen-2025-107894"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-107894","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]}}}